Skip to main content
. 2021 Sep 10;2(6):616–629. doi: 10.1158/2643-3230.BCD-21-0070

Figure 1.

Figure 1.

A, Treatment schema. Q, every. *One patient received HiDAC but did not receive pembrolizumab due to ongoing grade 3 diarrhea and was thus replaced on this study. B, ORR among different patient subsets. CRi, CR with incomplete platelet recovery; MLFS, morphologic leukemia-free state; PR, partial remission.